Skip to main content
Clinical Trials/NCT02359240
NCT02359240
Unknown
Not Applicable

Skeletal Muscle Wasting in Patients With Sepsis

Changhai Hospital1 site in 1 country50 target enrollmentDecember 2014
ConditionsSepsisAtrophy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sepsis
Sponsor
Changhai Hospital
Enrollment
50
Locations
1
Primary Endpoint
HO-1 mRNA and protein expression, mitochondria function of musculus vastus lateralis
Last Updated
11 years ago

Overview

Brief Summary

The current project was designed to examine dynamic changes in muscle wasting during sepsis. Researchers will focus the mitochondrial dysfunction of muscle cells and investigate the role of HO-1 in it. Researchers interested in identifying factors involved in the pathology of muscle wasting during sepsis.

Detailed Description

Rapid muscle atrophy or muscle wasting occured to septic patients.Sepsis induced muscle wasting has become a severe, frequent, and persistent complication among critically ill patients. Multiple factors including ubiquitin-proteasome system, proinflammatory cytokines and oxidative stress contribute muscle proteolysis. It is known that heme oxygenase-1 (HO-1) possesses a variety of functions like anti-inflammatory, antioxidative and anti-apoptosis effects. In order to investigate the mechanisms under the condition, researchers are going to examine the role of HO-1 in muscle atrophy during sepsis.

Registry
clinicaltrials.gov
Start Date
December 2014
End Date
August 2016
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Xiaoming Deng

Chief, Professer

Changhai Hospital

Eligibility Criteria

Inclusion Criteria

  • sepsis, severe sepsis, septic shock
  • clinical reason for fixation surgery of femoral fractures

Exclusion Criteria

  • no informed consent
  • medical history of myopathy
  • unintended weight loss before surgery or ICU admission
  • chronic use of corticosteroids

Outcomes

Primary Outcomes

HO-1 mRNA and protein expression, mitochondria function of musculus vastus lateralis

Time Frame: 3 days after diagnosis

Secondary Outcomes

  • length of ICU stay(60 days)
  • muscle myosin content(3 days after diagnosis)
  • length of mechanical ventilation(60 days)

Study Sites (1)

Loading locations...

Similar Trials